Toxicity and Patterns of Failure of Adaptive/Ablative Proton Therapy for Early-Stage, Medically Inoperable Non-Small Cell Lung Cancer

Proton therapy to ablative doses is well tolerated and produces promising local control rates for medically inoperable early-stage NSCLC.